Simvastatin combined trimetazidine on the cardiac function of patients with chronic heart failure
objective to investigate the simvastatin associated with trimetazidine is applied to the curative effect of treatment of chronic heart failure (CHF). Methods 76 patients with CHF were divided into control group and observation group, al the 38 cases, control group given routine therapy heart failure, treatment group on the basis of the above plus simvastatin associated with trimetazidine treatment, compared two groups of cardiac function before and after the treatment. Results and cardiac function in treatment of total effective observation group was obviously higher than that of control group (P < 0.05) conclusion simvastatin and trimetazidine joint used in the treatment of CHF, patients can improve heart function, worth clinical promotion.